JP2023553532A5 - - Google Patents
Info
- Publication number
- JP2023553532A5 JP2023553532A5 JP2023560239A JP2023560239A JP2023553532A5 JP 2023553532 A5 JP2023553532 A5 JP 2023553532A5 JP 2023560239 A JP2023560239 A JP 2023560239A JP 2023560239 A JP2023560239 A JP 2023560239A JP 2023553532 A5 JP2023553532 A5 JP 2023553532A5
- Authority
- JP
- Japan
- Prior art keywords
- egfr
- cancer
- composition according
- pharmaceutically acceptable
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124665P | 2020-12-11 | 2020-12-11 | |
| US63/124,665 | 2020-12-11 | ||
| US202163214718P | 2021-06-24 | 2021-06-24 | |
| US63/214,718 | 2021-06-24 | ||
| US202163253012P | 2021-10-06 | 2021-10-06 | |
| US63/253,012 | 2021-10-06 | ||
| US202163277561P | 2021-11-09 | 2021-11-09 | |
| US63/277,561 | 2021-11-09 | ||
| PCT/US2021/062912 WO2022125962A1 (en) | 2020-12-11 | 2021-12-10 | Combination therapies for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553532A JP2023553532A (ja) | 2023-12-21 |
| JP2023553532A5 true JP2023553532A5 (enExample) | 2024-12-17 |
Family
ID=81974006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560239A Pending JP2023553532A (ja) | 2020-12-11 | 2021-12-10 | 癌の処置のための併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240050441A1 (enExample) |
| EP (1) | EP4259147A4 (enExample) |
| JP (1) | JP2023553532A (enExample) |
| KR (1) | KR20230154793A (enExample) |
| AU (1) | AU2021396395A1 (enExample) |
| CA (1) | CA3201657A1 (enExample) |
| WO (1) | WO2022125962A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12122787B2 (en) | 2019-09-20 | 2024-10-22 | Shanghai Jemincare Pharmaceuticals Co., Ltd | Fused pyridone compound, and preparation method therefor and use thereof |
| US20240102099A1 (en) * | 2020-11-20 | 2024-03-28 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Methods and compositions relating to a novel epidermal growth factor receptor (egfr) splice variant |
| US20250195533A1 (en) * | 2020-12-11 | 2025-06-19 | Erasca, Inc. | Combination therapies for the treatment of cancer |
| US20240293422A1 (en) * | 2021-06-24 | 2024-09-05 | Erasca, Inc. | Shp2 and cdk4/6 inhibitors combination therapies for the treatment of cancer |
| TW202322809A (zh) * | 2021-10-06 | 2023-06-16 | 美商艾瑞斯卡公司 | 三取代雜芳基衍生物作為src同源-2磷酸酶抑制劑之用途 |
| WO2025226830A1 (en) * | 2024-04-23 | 2025-10-30 | Erasca, Inc. | Shp2 and egfr inhibitors for the treatment of chordoma |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG188802A1 (en) * | 2008-03-06 | 2013-04-30 | Genentech Inc | Combination therapy with c-met and egfr antagonists |
| US8828391B2 (en) * | 2011-05-17 | 2014-09-09 | Boehringer Ingelheim International Gmbh | Method for EGFR directed combination treatment of non-small cell lung cancer |
| JP2016503399A (ja) * | 2012-10-25 | 2016-02-04 | ノバルティス アーゲー | 組合せ |
| US20140308274A1 (en) * | 2013-03-15 | 2014-10-16 | Mirna Therapeutics, Inc. | Combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki inhibitors |
| JP7337174B2 (ja) * | 2018-09-18 | 2023-09-01 | ニカング セラピューティクス， インコーポレイテッド | Ｓｒｃホモロジー－２ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体 |
| JP2022526159A (ja) * | 2019-03-29 | 2022-05-23 | アストラゼネカ・アクチエボラーグ | 非小細胞肺がんの治療に使用するためのオシメルチニブ |
| CA3164995A1 (en) * | 2019-12-20 | 2021-06-24 | Erasca, Inc. | Tricyclic pyridones and pyrimidones |
| WO2021173923A1 (en) * | 2020-02-28 | 2021-09-02 | Erasca, Inc. | Pyrrolidine-fused heterocycles |
-
2021
- 2021-12-10 EP EP21904509.3A patent/EP4259147A4/en not_active Withdrawn
- 2021-12-10 CA CA3201657A patent/CA3201657A1/en active Pending
- 2021-12-10 WO PCT/US2021/062912 patent/WO2022125962A1/en not_active Ceased
- 2021-12-10 US US18/256,089 patent/US20240050441A1/en not_active Abandoned
- 2021-12-10 AU AU2021396395A patent/AU2021396395A1/en not_active Abandoned
- 2021-12-10 JP JP2023560239A patent/JP2023553532A/ja active Pending
- 2021-12-10 KR KR1020237023446A patent/KR20230154793A/ko not_active Abandoned